CY1120386T1 - Συνθεση για τη διαχειριση της ναυτιας και του εμετου - Google Patents
Συνθεση για τη διαχειριση της ναυτιας και του εμετουInfo
- Publication number
- CY1120386T1 CY1120386T1 CY20181100691T CY181100691T CY1120386T1 CY 1120386 T1 CY1120386 T1 CY 1120386T1 CY 20181100691 T CY20181100691 T CY 20181100691T CY 181100691 T CY181100691 T CY 181100691T CY 1120386 T1 CY1120386 T1 CY 1120386T1
- Authority
- CY
- Cyprus
- Prior art keywords
- effective amount
- marine
- management
- vehicle
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361856971P | 2013-07-22 | 2013-07-22 | |
| PCT/CA2014/050231 WO2015010194A1 (en) | 2013-07-22 | 2014-03-13 | Composition for the management of nausea and vomiting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120386T1 true CY1120386T1 (el) | 2019-07-10 |
Family
ID=50877783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100691T CY1120386T1 (el) | 2013-07-22 | 2018-07-03 | Συνθεση για τη διαχειριση της ναυτιας και του εμετου |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US10028941B2 (enExample) |
| EP (1) | EP3024466B1 (enExample) |
| JP (1) | JP6379194B2 (enExample) |
| KR (1) | KR102242391B1 (enExample) |
| CN (1) | CN105492013B (enExample) |
| AR (1) | AR097023A1 (enExample) |
| AU (1) | AU2014295765B2 (enExample) |
| BR (1) | BR112016001474A2 (enExample) |
| CA (1) | CA2847022C (enExample) |
| CL (1) | CL2016000154A1 (enExample) |
| CY (1) | CY1120386T1 (enExample) |
| DK (1) | DK3024466T3 (enExample) |
| EA (1) | EA029690B1 (enExample) |
| ES (1) | ES2670619T3 (enExample) |
| HU (1) | HUE039131T2 (enExample) |
| IL (1) | IL243638B (enExample) |
| MX (1) | MX366760B (enExample) |
| MY (1) | MY191347A (enExample) |
| NO (1) | NO3086669T3 (enExample) |
| NZ (1) | NZ716017A (enExample) |
| PL (1) | PL3024466T3 (enExample) |
| PT (1) | PT3024466T (enExample) |
| SA (1) | SA516370443B1 (enExample) |
| SG (1) | SG11201600122RA (enExample) |
| TW (2) | TWI654977B (enExample) |
| UY (1) | UY35674A (enExample) |
| WO (1) | WO2015010194A1 (enExample) |
| ZA (1) | ZA201600383B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104136004B (zh) | 2012-02-22 | 2018-03-06 | 达切斯内公司 | 多西拉敏和吡哆醇和/或其代谢物或盐的制剂 |
| ES2670619T3 (es) | 2013-07-22 | 2018-05-31 | Duchesnay Inc. | Composición para la gestión de náuseas y vómitos |
| TWI595874B (zh) | 2014-08-29 | 2017-08-21 | 達契斯奈股份有限公司 | 多西拉敏及吡哆醇及／或其代謝產物或鹽之多模式釋放調配物 |
| US10244873B2 (en) | 2015-10-01 | 2019-04-02 | Isee Store Innovations, Llc | Adjustable product display system and method |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8518301D0 (en) | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
| GB8524001D0 (en) | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| US4842867A (en) | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
| IT1201136B (it) | 1987-01-13 | 1989-01-27 | Resa Farma | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive |
| US5110597A (en) | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
| US5017381A (en) | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
| US5387421A (en) | 1991-01-31 | 1995-02-07 | Tsrl, Inc. | Multi stage drug delivery system |
| NZ286242A (en) | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
| US5260068A (en) | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
| US5260069A (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
| DE19716732C2 (de) | 1997-03-07 | 1999-03-25 | Max Delbrueck Centrum | Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
| US7744916B2 (en) | 1997-06-11 | 2010-06-29 | Umd, Inc. | Coated vaginal device for delivery of anti-migraine and anti-nausea drugs |
| FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
| JP2002541092A (ja) | 1999-04-06 | 2002-12-03 | ファーマクエスト・リミテッド | メチルフェニデートのパルス性送達のための薬学的投薬形態 |
| US6197329B1 (en) | 1999-05-03 | 2001-03-06 | Drugtech Corporation | Anti-nausea compositions and methods |
| US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
| AU4305101A (en) | 1999-11-22 | 2001-06-04 | Research Foundation Of The State University Of New York, The | Magnetic nanoparticles for selective therapy |
| US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
| US6500457B1 (en) | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| US6924273B2 (en) | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
| CA2350195C (en) | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| CA2432438C (en) | 2001-01-09 | 2011-04-26 | Microchips, Inc. | Flexible microchip devices for ophthalmic and other applications |
| US6997863B2 (en) | 2001-07-25 | 2006-02-14 | Triton Biosystems, Inc. | Thermotherapy via targeted delivery of nanoscale magnetic particles |
| US7704542B2 (en) * | 2001-09-12 | 2010-04-27 | Xanodyne Pharmaceuticals, Inc. | Vitamin/mineral compositions with DHA |
| CA2392486A1 (en) | 2002-07-05 | 2002-12-08 | Duchesnay Inc. | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| JP4436258B2 (ja) | 2002-08-16 | 2010-03-24 | マイクロチップス・インコーポレーテッド | 制御された放出デバイスおよび方法 |
| GB0229725D0 (en) | 2002-12-19 | 2003-01-29 | Univ Wales Medicine | Haplotype partitioning and growth hormone SNPs |
| US20100221321A1 (en) | 2003-02-27 | 2010-09-02 | Innercap Technologies, Inc. | Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions |
| JP5107041B2 (ja) | 2004-09-01 | 2012-12-26 | マイクロチップス・インコーポレーテッド | レザバ内容物の制御された放出または曝露のための、マルチキャップレザバデバイス |
| GB0502475D0 (en) | 2005-02-07 | 2005-03-16 | Sb Pharmco Inc | Novel compositions |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| US20070141147A1 (en) | 2005-12-21 | 2007-06-21 | Auriga Laboratories, Inc. | Sequential release pharmaceutical formulations |
| US20090004281A1 (en) | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
| CA2713128C (en) | 2008-01-25 | 2016-04-05 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| KR101190708B1 (ko) | 2010-03-12 | 2012-10-12 | 주식회사 대웅제약 | 모사프리드 또는 이의 염을 포함하는 서방형 약학 조성물 |
| EP2555756B1 (en) | 2010-04-07 | 2018-08-22 | Lupin Limited | Controlled release pharmaceutical compositions of tapentadol |
| WO2011163206A2 (en) | 2010-06-22 | 2011-12-29 | Twi Pharmaceuticals, Inc. | Controlled release compositions with reduced food effect |
| WO2012112437A1 (en) | 2011-02-14 | 2012-08-23 | The Procter & Gamble Company | Filmcoated solid dosage forms comprising honey in the coating |
| EP2717860A4 (en) | 2011-06-08 | 2014-11-05 | Sti Pharma Llc | FORMULATION FROM A WATER SOLUBLE AND PHARMACEUTICALLY ACTIVE ORGANIC COMPOUND WITH CONTROLLED ABSORPTION FOR ONLY DAILY APPLICATION |
| CN104136004B (zh) | 2012-02-22 | 2018-03-06 | 达切斯内公司 | 多西拉敏和吡哆醇和/或其代谢物或盐的制剂 |
| WO2013123569A1 (en) | 2012-02-22 | 2013-08-29 | Duchesnay Inc. | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| ES2670619T3 (es) | 2013-07-22 | 2018-05-31 | Duchesnay Inc. | Composición para la gestión de náuseas y vómitos |
-
2014
- 2014-03-13 ES ES14829076.0T patent/ES2670619T3/es active Active
- 2014-03-13 US US14/907,248 patent/US10028941B2/en not_active Expired - Fee Related
- 2014-03-13 TW TW106104622A patent/TWI654977B/zh not_active IP Right Cessation
- 2014-03-13 MX MX2016000884A patent/MX366760B/es active IP Right Grant
- 2014-03-13 EP EP14829076.0A patent/EP3024466B1/en not_active Not-in-force
- 2014-03-13 KR KR1020167004284A patent/KR102242391B1/ko not_active Expired - Fee Related
- 2014-03-13 WO PCT/CA2014/050231 patent/WO2015010194A1/en not_active Ceased
- 2014-03-13 CN CN201480046412.7A patent/CN105492013B/zh not_active Expired - Fee Related
- 2014-03-13 PL PL14829076T patent/PL3024466T3/pl unknown
- 2014-03-13 PT PT148290760T patent/PT3024466T/pt unknown
- 2014-03-13 JP JP2016528268A patent/JP6379194B2/ja not_active Expired - Fee Related
- 2014-03-13 MY MYPI2016700064A patent/MY191347A/en unknown
- 2014-03-13 EA EA201690149A patent/EA029690B1/ru unknown
- 2014-03-13 AU AU2014295765A patent/AU2014295765B2/en not_active Ceased
- 2014-03-13 TW TW103109070A patent/TWI589292B/zh not_active IP Right Cessation
- 2014-03-13 SG SG11201600122RA patent/SG11201600122RA/en unknown
- 2014-03-13 DK DK14829076.0T patent/DK3024466T3/en active
- 2014-03-13 NZ NZ716017A patent/NZ716017A/en not_active IP Right Cessation
- 2014-03-13 HU HUE14829076A patent/HUE039131T2/hu unknown
- 2014-03-13 BR BR112016001474-0A patent/BR112016001474A2/pt not_active Application Discontinuation
- 2014-03-14 CA CA2847022A patent/CA2847022C/en not_active Expired - Fee Related
- 2014-03-27 US US14/228,214 patent/US9452181B2/en not_active Expired - Fee Related
- 2014-07-22 AR ARP140102727A patent/AR097023A1/es unknown
- 2014-07-22 UY UY0001035674A patent/UY35674A/es not_active Application Discontinuation
- 2014-10-03 US US14/506,387 patent/US9439920B2/en not_active Expired - Fee Related
-
2015
- 2015-10-15 NO NO15794300A patent/NO3086669T3/no unknown
-
2016
- 2016-01-17 IL IL243638A patent/IL243638B/en active IP Right Grant
- 2016-01-19 ZA ZA2016/00383A patent/ZA201600383B/en unknown
- 2016-01-21 CL CL2016000154A patent/CL2016000154A1/es unknown
- 2016-01-21 SA SA516370443A patent/SA516370443B1/ar unknown
-
2018
- 2018-07-03 CY CY20181100691T patent/CY1120386T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121468T1 (el) | Συνδυασμος παραγωγων πυρρολο[2,3-d]πυριμιδινης με εναν ή περισσοτερους επιπροσθετους παραγοντες ως αναστολεις των σχετικων me janus (ιανος) kinασων (jak) | |
| CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
| CY1120104T1 (el) | Αναστολεις της syk | |
| EA201690223A1 (ru) | Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение | |
| CY1123167T1 (el) | Σταθεροποιημενο σκευασμα βιταμινης d τροποποιημενης απελευθερωσης και μεθοδος χορηγησης αυτου | |
| CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
| ECSP18090046A (es) | Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| CY1119842T1 (el) | Συντηγμενες τρικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις ιντεγκρασης hiv | |
| CY1120480T1 (el) | Ενωσεις πυραζολοπυριμιδινης | |
| CY1121089T1 (el) | Χρηση των παραγωγων της βενζιμιδαζολης-προλινης | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| GT201300236A (es) | Derivados de pirrolo (2,3-d) pirimidina como inhibidores de quinasa relacionados con tropomiosina | |
| CY1121829T1 (el) | Κατιονικα πολυμερη που εχουν τη βαση τους στο γλυκογονο | |
| EA201790923A1 (ru) | Производные бетулина | |
| EA201690478A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТРИАЗОЛ[4,5-d]ПИРИМИДИНА | |
| EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
| EA201591805A1 (ru) | Оксабицикло [2.2.2] кислоты - модуляторы gpr120 | |
| EA201600121A1 (ru) | Новые индольные и пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| BR112016007414A2 (pt) | método de produção de um comprimido de monocamada, e, comprimido de monocamada | |
| EA201591939A1 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРА CB2 | |
| EA201500931A1 (ru) | Производные пиридин-4-ила | |
| MX2014008594A (es) | Formulacion de doxilamina y piridoxina y/o sus metabolitos o sales. | |
| CR20160016A (es) | Pirazolpiridinas sustituidas | |
| EA201791600A1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
| EA201591795A1 (ru) | Бицикло[2.2.1]-кислоты в качестве модуляторов рецептора gpr120 |